Mass General s Substance Use Disorder Initiative

Size: px
Start display at page:

Download "Mass General s Substance Use Disorder Initiative"

Transcription

1 Mass General s Substance Use Disorder Initiative Martha Kane, PhD Sarah Wakeman, MD, FASAM Clinical and Medical Directors, Mass General Hospital Substance Use Disorder Initiative

2 None Disclosures

3 Objectives Understand substance use disorder as a chronic illness Describe effective treatment for substance use disorder Review Mass General s response to the current opioid use disorder & other SUD crisis

4 Initial State Limited benefit from current treatment models High acuity, med + psych + substance dx Limited success in treatment outcome Lack of integrated treatment options, limited evidence based care Significant social needs unmet (social determinants of health) Care is poorly coordinated, short term focus, in silos with limited communication Challenge: How can current models be modified to address needs and break the cycle? 4

5 Drug overdoses now leading cause of death for Americans under 50

6 National Opioid-Related Inpatient Hospitalizations and ED Visits

7 Prevalence of Substance Use Disorder SAMHSA National Survey on Drug Use and Health. Retrieved from

8 As we have seen repeatedly in the history of medicine, science is one of the strongest allies in resolving public health crises. Ending the opioid epidemic will not be any different.

9 Understanding Addiction The question is frequently asked: Why does a man become a drug addict? The answer is that he usually does not intend to. Junk wins by default. I tried it as a matter of curiosity. I drifted along taking shots when I could score. I ended up hooked. You don t decide to be an addict. One morning you wake up sick and you re an addict. William S. Burroughs, Junky (1953)

10 Natural History of Opioid Use Disorder Using to feel good Needing to use more to feel normal Using to keep from getting sick

11 When you can stop you don't want to, and when you want to stop, you can't. Luke Davies, Candy

12 A Disease of Gene-Environment- Development Biology Genes/Development Environment DRUG/ALCOHOL Brain Mechanisms Slide courtesy of Dr. Compton, NIDA Addiction

13 Addiction Primary, chronic brain disease characterized by compulsive drug seeking and use despite harmful consequences Involves cycles of recurrence and remission 40-60% genetic American Society of Addiction Medicine. April 12, NIDA. August,

14 Substance Use Disorder Changes Brain Structure and Function Decreased Heart Metabolism in Coronary Artery Disease High Decreased Brain Metabolism in Substance Use Disorder Healthy heart Diseased Heart Low Healthy Brain Diseased Brain Slide Courtesy of NIDA

15 Volkow et al. J. Neurosci., December 1, 2001, 21(23): Visualizing Recovery

16 A Treatable Disease NIDA. Principles of Drug Addiction Treatment McLellan et al., JAMA, 284: , 2000.

17 What is Effective Treatment? Pharmacotherapy Recovery Supports Psychosocial Interventions

18 Similar to Management of Diabetes No cure Goal is euglycemia and prevention of acute and chronic complications Individualized treatment plans and targets Treatment includes: Medication Lifestyle changes Regular monitoring for complications Behavioral support

19 Short-term Detoxification Ineffective Chutuape et al. Am J Drug Alcohol Abuse Feb;27(1):19-44.

20 What is Effective Treatment? Buprenorphine Maintenance 75% retained in treatment 75% abstinent by toxicology Detoxification 0% retained in treatment 20% died Kakko et al. Lancet Feb 22;361(9358):662-8

21 Treatment Retention Higher Sees et al. JAMA. 2000;283(10):

22 Mortality Decreased All cause mortality rates (per 1000 person years): In methadone treatment: 11.3 Out of methadone treatment: 36.1 In buprenorphine treatment: 4.3 Out of buprenorphine treatment: 9.5 Overdose mortality rates: In methadone treatment: 2.6 Out of methadone treatment: 12.7 In buprenorphine treatment: 1.4 Out of buprenorphine treatment: 4.6 Sordo et al. BMJ 2017;357:j1550

23 Treatment Selection: Belief versus Science We as a society think [people with addiction] should just get off drugs and by strenuously hauling up on their own bootstraps should stay off no matter what. Policymakers and some clinicians continue to promote detoxification as treatment, even though detoxification does nothing to help people stay off drugs. Ling W. J Neuroimmune Pharmacol (2016) 11:

24 Medications for Addiction Treatment Work

25 Long-term Treatment In most cases, treatment will be required in the long term or even throughout life. Such long-term treatment, common for many medical conditions, should not be seen as treatment failure, but rather as a costeffective way of prolonging life and improving quality of life, supporting the natural and long-term process of change and recovery. World Health Organization

26 Hospitals Have Opportunity to Initiate Treatment Initiating methadone in hospital: 82% present for follow-up addiction care Buprenorphine vs. detox among inpatients: Bupe: 72.2% enter into treatment after discharge Detox : 11.9% enter treatment after discharge Buprenorphine vs. referral in ED: Bupe: 78% engaged in treatment at 30 days Referral: 37% engaged in treatment at 30 days J Gen Intern Med. Aug 2010; 25(8): ; JAMA Intern Med 2014 Aug;174(8): ; D'Onofrio et al. JAMA 2015 Apr 28;313(16):

27 A Monumental Lost Opportunity USE n-research/reports/national-survey- primary-care-physicians-patients-

28 SUDs Initiative Mission To improve the quality, clinical outcomes and value of addiction treatment for all MGH patients with SUD. To accomplish this mission, patients must have access to evidence based treatment that is readily available and standardized across the system.

29 Solution: Modify treatment structure and approach Decision Support: Decision support tools Evidence based guidelines Care Delivery System: Treatment on demand access to evidence based treatment MAT Evidence based Behavioral Health tx Psychopharmacology Relapse expected, treated Chronic Care Model HIV/AIDS Self-Management/Community Involvement: Patient centered care, patient driven Peer based services integrated into all levels of care Effective linkage to non-medical supports Navigation services - connection, connection, connection Clinical Information Systems: Registries Outcomes measured Treatment plans modified based on outcomes 29 29

30 Developing a True Continuum of Care Recovery Coaches Inpatient (ACT) Bridge Clinic Outpatient Community Prevention, Education & Evaluation

31 An Example of a Health System Response Inpatient Addiction Consult Team Outpatient Addiction Champion Teams The MGH Substance Use Disorder Initiative Urgent Bridge Clinic Recovery Coaches

32 1 Among patients with SUD Dx code on floors where ACT available; Controlled for type of substance, gender, age 2 remained statistically significant in intention-to-treat analysis and after controlling for age, gender, employment status, smoking status, and baseline days abstinent (p=0.02) Patients Seen by Addiction Consult Team Have Lower Readmission Rates, Increased Abstinence ACT Consults: 3815consults on 2563 patients 32% involved opioids 70% male, mean age Change in Days Abstinent Intervention Patients seen by ACT have lower 30-day readmission (14.6% vs 17.7%) Initial 30 Day Follow-Up

33 Bridge Clinic Provided 4,039 On Demand Visits for 459 Patients Flexible model crucial: 50% visits not scheduled ahead Support for ED, providing same day or next day medication for OD patients; served 55 patients to date Expanding to 7 day/wk coverage For recent inpatients, 10.4% readmitted within 30 days Overall, 16% of Bridge Clinic patients had subsequent inpatient stay, 33% had ED visit

34 Outpatient: Transforming Care In 8 health center/primary care practices Multidisciplinary SUDs champions teams, risk rounds 38 physicians waivered to prescribe buprenorphine in CHCs 546 patients currently receiving buprenorphine treatment in CHCs Behavioral health services Embedded in PCP practices Expanded behavioral health capacity via training for existing staff Treatment for family members 34

35 Patients with Recovery Coaches Have Fewer Inpatient Admissions 10 Recovery Coaches and 1 Recovery Coach manager 1028 patients touched 10% reduction hospitalizations, increase in primary care & MH visits Patients report Improved patient experience Facilitated access to social services Ongoing social support

36 Improving Quality of Life If you think you're going to have a bad day, the best thing is try to get [the coach] first and then say, Look, I'm having a bad day. Is it possible you could come and sit in with me? Patient I guess she [recovery coach] has family who has gone through, who had endocarditis and stuff, so I felt a sense of relation that opened the door that I don't feel with the doctors. Patient Had my first overdose after 20 years of IV drug use. I can describe my thought and feelings, after being saved by narcan in one word along grateful! This medication/drug is saving lives. Thank God. God bless. Keep the faith. Today is my birthday and I have received the best present ever... Another chance at life. So grateful for my family, so grateful for my health, so grateful for this program [Bridge Clinic]. And a grateful heart will never relapse. -Patient

37 What s Next? Extending model to new settings: Pediatrics: Champions Embedded BH care Family care Oncology Tumor Board for SUD Enhanced psychiatric services OB/GYN HOPE Clinic Review of rules about reporting Extending access: Bridge Clinic open 7 days/week Inpatient Addiction Consult support available 24/7 37

38 What s Next? Continued integration throughout primary care IMA, BMG Recovery coaches, multidisciplinary clinical rounds Education and Support Training for Buprenorphine waiver Mentoring for new Buprenorphine prescribers Professional Training Addiction Medicine fellowship CARN 38

MGH Substance Use Disorder Initiative. Dawn Williamson, RN, DNP, PMHCNS-BC, CARN-AP MGH ED Christopher Shaw, RN, ANP, PMHNP-BC, CARN-AP MGH ACT

MGH Substance Use Disorder Initiative. Dawn Williamson, RN, DNP, PMHCNS-BC, CARN-AP MGH ED Christopher Shaw, RN, ANP, PMHNP-BC, CARN-AP MGH ACT Bridging the Gap: Bridging the Gaps to addiction treatment through comprehensive collaborative practice among Advanced Practice Nurses in a large urban Medical Center Dawn Williamson, RN, DNP, PMHCNS-BC,

More information

Treating Addiction as a Chronic Disease

Treating Addiction as a Chronic Disease Treating Addiction as a Chronic Disease Sarah E. Wakeman, MD, FASAM Medical Director, MGH Substance Use Disorder Initiative Assistant Professor of Medicine, Harvard Medical School Disclosures Neither I

More information

Opioid Use Disorder Treatment Initiation in Diverse Settings

Opioid Use Disorder Treatment Initiation in Diverse Settings Opioid Use Disorder Treatment Initiation in Diverse Settings Sarah Wakeman, MD, FASAM Medical Director, Mass General Substance Use Disorder Initiative Assistant Professor, Harvard Medical School Disclosures

More information

The MGH Substance Use Disorder Initiative Sarah E. Wakeman, MD, FASAM Medical Director Assistant Professor of Medicine, Harvard Medical School

The MGH Substance Use Disorder Initiative Sarah E. Wakeman, MD, FASAM Medical Director Assistant Professor of Medicine, Harvard Medical School The MGH Substance Use Disorder Initiative Sarah E. Wakeman, MD, FASAM Medical Director Assistant Professor of Medicine, Harvard Medical School Disclosures Neither I nor my spouse/partner has a relevant

More information

Infectious Disease and the Opioid Epidemic: Correctional Health

Infectious Disease and the Opioid Epidemic: Correctional Health Infectious Disease and the Opioid Epidemic: Correctional Health Josiah Jody Rich, MD, MPH Professor of Medicine and Epidemiology, Brown University Director of the Center for Prisoner Health and Human Rights,

More information

9/17/2018 MISSION IMPOSSIBLE: IF YOU CHOOSE TO ACCEPT MISSION JOIN JUSTICE LEAGUE I M POSSIBLE HEPBURN

9/17/2018 MISSION IMPOSSIBLE: IF YOU CHOOSE TO ACCEPT MISSION JOIN JUSTICE LEAGUE I M POSSIBLE HEPBURN MISSION IMPOSSIBLE: IF YOU CHOOSE TO ACCEPT MISSION JOIN JUSTICE LEAGUE I M POSSIBLE HEPBURN 1 ADDICTION PREVENTION & TREATMENT SAVES LIVES According to the Food and Drug Administration s standards for

More information

The Chronic Disease of Addiction Evidence and Lessons from Practice

The Chronic Disease of Addiction Evidence and Lessons from Practice The Chronic Disease of Addiction Evidence and Lessons from Practice Laura G. Kehoe, MD, MPH Medical Director, MGH Substance Use Disorders Unit Bridge Clinic Massachusetts General Hospital Assistant Professor

More information

MGH Inpatient Addictions Consult Team Management of Opioid Use Disorder

MGH Inpatient Addictions Consult Team Management of Opioid Use Disorder MGH Inpatient Addictions Consult Team Management of Opioid Use Disorder Christopher Shaw RN, ANP, PMHNP, CARN AP Nursing Director, MGH, SUDS Initiative Addictions Consult Team Leader Objectives Understand

More information

QUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D.

QUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D. 2017 State Targeted Response to the Opioid Crisis Grants QUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D. H.R.6-21st Century Cures Act The 21st Century Cures Act is a United States law enacted

More information

Stigma, Myths, Realities Limit Access to Care

Stigma, Myths, Realities Limit Access to Care Stigma, Myths, Realities Limit Access to Care MARGARET RUKSTALIS, MD Director ACGME Addiction Medicine Fellowship @ Wake Forest School of Medicine No personal or family conflicts of interest or history

More information

The Opioid Crisis: What Can Physicians Do About It?

The Opioid Crisis: What Can Physicians Do About It? The Opioid Crisis: What Can Physicians Do About It? Richard S. Schottenfeld, M.D. Professor and Chair, Department of Psychiatry and Behavioral Sciences 2018 Louis J. Kolodner Memorial Lecture Disclosures

More information

Medicaid and the Opioid Crisis

Medicaid and the Opioid Crisis Medicaid and the Opioid Crisis Erica Floyd Thomas Bureau Chief of Medicaid Policy Agency for Health Care Administration Presented to: Medical Care Advisory Committee March 20, 2018 1 Florida Medicaid Covers

More information

Office Based Addiction Treatment (OBAT) at Lowell Community Health Center. Shaun Farraher, MD Melanie Priestly, Director May 2018

Office Based Addiction Treatment (OBAT) at Lowell Community Health Center. Shaun Farraher, MD Melanie Priestly, Director May 2018 Office Based Addiction Treatment (OBAT) at Lowell Community Health Center Shaun Farraher, MD Melanie Priestly, Director May 2018 Lowell CHC OBAT Program Snapshot Number of current active patients: 225

More information

Pennsylvania Coordinated Medication Assisted Treatment: A Penn State and Pennsylvania Psychiatric Institute Story

Pennsylvania Coordinated Medication Assisted Treatment: A Penn State and Pennsylvania Psychiatric Institute Story Pennsylvania Coordinated Medication Assisted Treatment: A Penn State and Pennsylvania Psychiatric Institute Story Sarah Sharfstein Kawasaki, MD Director of Addictions Services, Pennsylvania Psychiatric

More information

1) To understand the scope of the opioid epidemic with relation to Emergency Departments 2) To gain insight into some emerging Emergency Medicine

1) To understand the scope of the opioid epidemic with relation to Emergency Departments 2) To gain insight into some emerging Emergency Medicine 1) To understand the scope of the opioid epidemic with relation to Emergency Departments 2) To gain insight into some emerging Emergency Medicine solutions to the Opioid Epidemic 3) To learn about the

More information

The Value of Engagement in Substance Use Disorder (SUD) Treatment

The Value of Engagement in Substance Use Disorder (SUD) Treatment The Value of Engagement in Substance Use Disorder (SUD) Treatment A Report from Allegheny HealthChoices, Inc. June 2016 Introduction When considering substance use disorder (SUD) treatment, the length

More information

New Initiatives to Expand Access to Medication Assisted Treatment in NYS OASAS

New Initiatives to Expand Access to Medication Assisted Treatment in NYS OASAS New Initiatives to Expand Access to Medication Assisted Treatment in NYS OASAS Charles W. Morgan, MD, DFASAM, FAAFP Medical Director New York State Office of Alcoholism and Substance Abuse Services February

More information

ADDING EVEN MORE SUBSTANCE TO MANAGED CARE

ADDING EVEN MORE SUBSTANCE TO MANAGED CARE HEALTH WEALTH CAREER ADDING EVEN MORE SUBSTANCE TO MANAGED CARE OPTIMIZING MEDICAID TO RESPOND TO SUBSTANCE USE DISORDERS NATIONAL ACADEMY FOR STATE HEALTH POLICY 30TH ANNUAL STATE HEALTH POLICY CONFERENCE

More information

The Role of Primary Care Teams and the Medical Neighborhood in Addressing the Opioid Crisis in Maine. March 10, 2016

The Role of Primary Care Teams and the Medical Neighborhood in Addressing the Opioid Crisis in Maine. March 10, 2016 The Role of Primary Care Teams and the Medical Neighborhood in Addressing the Opioid Crisis in Maine March 10, 2016 Objectives Review current state of opioid crisis in Maine Briefly review physiology of

More information

SUBSTANCE USE DISORDER TREATMENT AND REFERRAL PROCESS

SUBSTANCE USE DISORDER TREATMENT AND REFERRAL PROCESS SUBSTANCE USE DISORDER TREATMENT AND REFERRAL PROCESS Presented by: John M. Connolly, Ph.D. Acting Deputy Director Los Angeles County Health Agency Department of Public Health Substance Abuse Prevention

More information

Pragmatic and Creative Responses to the Opioid Crisis in Connecticut

Pragmatic and Creative Responses to the Opioid Crisis in Connecticut Focusing on Highly Vulnerable Populations Track Pragmatic and Creative Responses to the Opioid Crisis in Connecticut A special thanks to our presenting sponsor: Presenters: Shawn Lang Deputy Director AIDS

More information

OPIOID USE DISORDER AND THE PSYCHIATRIC EMERGENCY ROOM THE VA CT MODEL

OPIOID USE DISORDER AND THE PSYCHIATRIC EMERGENCY ROOM THE VA CT MODEL OPIOID USE DISORDER AND THE PSYCHIATRIC EMERGENCY ROOM THE VA CT MODEL Brian Fuehrlein, MD PhD VA Connecticut Healthcare System and Yale University I have no conflicts of interest or relevant financial

More information

Buprenorphine and MAT 101

Buprenorphine and MAT 101 Buprenorphine and MAT 101 Why is Medication Assisted Treatment so Important for Recovery? KEN SAFFIER, MD 7 TH ANNUAL INTEGRATION SUMMIT DECEMBER 8, 2016 Disclosures: u Ken Saffier, MD, has nothing to

More information

Noel Schenk MD. Davis Behavioral Health

Noel Schenk MD. Davis Behavioral Health Noel Schenk MD Davis Behavioral Health Michael Botticelli Director of National Drug Control Policy What is Addiction? Addiction is defined as a chronic, relapsing brain disease that is characterized by

More information

Opioid Use Disorders &Medication Treatment

Opioid Use Disorders &Medication Treatment Agency medical director comments Opioid Use Disorders &Medication Treatment Charissa Fotinos, MD, MSc Deputy Chief Medical Officer Washington State Health Care Authority Learning Objectives: 1) Review

More information

Substance Use Disorders (SUDs) and Medication Assisted Treatment (MAT) for Opiates

Substance Use Disorders (SUDs) and Medication Assisted Treatment (MAT) for Opiates Substance Use Disorders (SUDs) and Medication Assisted Treatment (MAT) for Opiates What is MAT? Medication Assisted Treatment (MAT) is the use of medications, in addition to counseling, cognitive behavioral

More information

Treatment Can Work. SELECT A TOPIC...

Treatment Can Work.  SELECT A TOPIC... Page 1 of 8 SELECT A TOPIC..... NIDA Home > Drug Abuse and Addiction: One of America's Most Challenging Public Health Problems Treatment Can Work Drug Treatment Works Research has revealed a number of

More information

Injectable naltrexone (XR-NTX) A RETROSPECTIVE STUDY OF ITS ACCEPTANCE IN A COMMUNITY RECOVERY SETTING BRIANNE FITZGERALD MSN, PMHNP, CARN-AP

Injectable naltrexone (XR-NTX) A RETROSPECTIVE STUDY OF ITS ACCEPTANCE IN A COMMUNITY RECOVERY SETTING BRIANNE FITZGERALD MSN, PMHNP, CARN-AP Injectable naltrexone (XR-NTX) A RETROSPECTIVE STUDY OF ITS ACCEPTANCE IN A COMMUNITY RECOVERY SETTING BRIANNE FITZGERALD MSN, PMHNP, CARN-AP Overview Gavin Foundation Injectable naltrexone Community report

More information

Trends and Challenges: The Kentucky Opioid Crisis. Jason Smith, MD PhD University of Louisville

Trends and Challenges: The Kentucky Opioid Crisis. Jason Smith, MD PhD University of Louisville Trends and Challenges: The Kentucky Opioid Crisis Jason Smith, MD PhD University of Louisville Brief Introduction I am by no means an expert I have no financial disclosures Jokes are meant to be lighthearted

More information

Arwen Podesta, MD. ABIHM, ABAM, Forensic Psychiatry

Arwen Podesta, MD. ABIHM, ABAM, Forensic Psychiatry The State of Medicine in Addiction Recovery Arwen Podesta, MD ABIHM, ABAM, Forensic Psychiatry www.podestawellness.com 504-252-0026 http://www.addictionpolicy.org/ Overview Addiction is a serious, chronic

More information

Medication Assisted Treatment: Right for you, Right for your Recovery? Robert Matylewicz, DO, FASAM Medical Director, Clarity Way Inc.

Medication Assisted Treatment: Right for you, Right for your Recovery? Robert Matylewicz, DO, FASAM Medical Director, Clarity Way Inc. Medication Assisted Treatment: Right for you, Right for your Recovery? Robert Matylewicz, DO, FASAM Medical Director, Clarity Way Inc. Elements Behavioral Health Diplomate, American Board of Addiction

More information

Treatment of Youth Opioid Addiction: Approaches to a Modern Epidemic. What should we do with this case? Heroin Addiction History

Treatment of Youth Opioid Addiction: Approaches to a Modern Epidemic. What should we do with this case? Heroin Addiction History Treatment of Youth Opioid Addiction: Approaches to a Modern Epidemic What should we do with this case? 17 M Onset prescription opioids 15, progressing to daily use with withdrawal within 8 months Onset

More information

Wasted AN INTRODUCTION TO SUBSTANCE ABUSE

Wasted AN INTRODUCTION TO SUBSTANCE ABUSE Wasted AN INTRODUCTION TO SUBSTANCE ABUSE Dr. Brian L. Bethel Child and Family Therapist Independent Trainer and Consultant LPCC-S, LCDC III, RPT-S www.brianlbethel.com INTERPLAY COUNSELING & CONSULTING

More information

Mental Health and Behavioral Health

Mental Health and Behavioral Health Mental Health and Behavioral Health mpfc (AC) Insula Thal DS GP VS VS VTA VTA Hippo OFC Wilson M. Compton, M.D., M.P.E. Deputy Director National Institute on Drug Abuse Advancing Addiction Science Behavioral

More information

8/16/2018. California s MAT Expansion Hub and Spoke System: Provider and Consumer Perspectives. Agenda. No Wrong Door

8/16/2018. California s MAT Expansion Hub and Spoke System: Provider and Consumer Perspectives. Agenda. No Wrong Door California s MAT Expansion Hub and Spoke System: Provider and Consumer Perspectives Gloria Miele, PhD, Learning Collaborative Coordinator, Hub and Spoke MAT Expansion Project Richard Rawson, PhD, Professor

More information

RI Centers of Excellence for the

RI Centers of Excellence for the RI Centers of Excellence for the Treatment of Opioid Use Disorder COE CODAC Behavioral Healthcare Linda Hurley President/CEO 9-18-17 for the Warren Alpert Medical School of Brown University RI s Strategic

More information

7/7/2016 Journal of the American Medical Association,

7/7/2016 Journal of the American Medical Association, 1 2 Journal of the American Medical Association, 2008 3 The Clinical Trial 152 Adolescents and Young Adults (Age 15 to 21) randomly assigned to either; 1. 2 weeks of Buprenorphine detox 2. 12 weeks of

More information

The Value of Peer Support in Behavioral Health Services HARVEY ROSENTHAL, NYAPRS EMILY KINGMAN, ICL DEIDRE SUMMERS, ICL ANDRE JORDAN, ICL

The Value of Peer Support in Behavioral Health Services HARVEY ROSENTHAL, NYAPRS EMILY KINGMAN, ICL DEIDRE SUMMERS, ICL ANDRE JORDAN, ICL The Value of Peer Support in Behavioral Health Services HARVEY ROSENTHAL, NYAPRS EMILY KINGMAN, ICL DEIDRE SUMMERS, ICL ANDRE JORDAN, ICL Introduction & Housekeeping Housekeeping: Slides are posted at

More information

Care in the Face of the Opioid Epidemic: How Yale University and Yale New Haven Hospital are Reaching Underserved Communities

Care in the Face of the Opioid Epidemic: How Yale University and Yale New Haven Hospital are Reaching Underserved Communities Care in the Face of the Opioid Epidemic: How Yale University and Yale New Haven Hospital are Reaching Underserved Communities Jeanette M. Tetrault, MD FACP FASAM Associate Professor of Medicine Program

More information

Methadone and Naltrexone ER

Methadone and Naltrexone ER Methadone and Naltrexone ER Laura G. Kehoe, MD, MPH, FASAM Medical Director MGH Substance Use Disorder Bridge Clinic Assistant Professor of Medicine Harvard Medical School Disclosures Neither I nor my

More information

SUBSTANCE USE DISORDER (SUD) TREATMENT

SUBSTANCE USE DISORDER (SUD) TREATMENT SUBSTANCE USE DISORDER (SUD) TREATMENT CONTINUUM OF CARE OVERVIEW Behavioral Health Advisory Board April 6, 2017 Piedad Garcia & Yael Koenig 3-26-17 OVERVIEW Continuum of Care Target Population CADRE Ancillary

More information

Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center

Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center Data from the National Vital Statistics System Mortality The age-adjusted rate of drug overdose deaths in the United States

More information

Medication Supported Recovery- A Review of Evidence-Based Practice

Medication Supported Recovery- A Review of Evidence-Based Practice Medication Supported Recovery- A Review of Evidence-Based Practice Andrew B. Mendenhall, MD, DABAM, DABFM, Senior Medical Director, Substance Use Disorder Services, Central City Concern 1 Objectives 1.

More information

Trigger. Myths About the Use of Medication in Recovery BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS

Trigger. Myths About the Use of Medication in Recovery BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS Module VI Counseling Buprenorphine Patients Myths About the Use of Medication in Recovery! Patients are still addicted!

More information

PITTSBURGH MERCY: COMPREHENSIVE INTEGRATED CARE JUNE 6, 2018

PITTSBURGH MERCY: COMPREHENSIVE INTEGRATED CARE JUNE 6, 2018 PITTSBURGH MERCY: COMPREHENSIVE INTEGRATED CARE JUNE 6, 2018 AN ENHANCED MEDICAL HOME MODEL FOR THE SMI POPULATION Comprehensive Care Patient Centered Care Coordinated Care Accessible Services Quality

More information

Opioid use disorder: Supporting recovery with a medication-assisted treatment approach

Opioid use disorder: Supporting recovery with a medication-assisted treatment approach Executive Summary Opioid use disorder: Supporting recovery with a medication-assisted treatment approach Opioid overprescription: Cause and effect The United States is currently facing an opioid-use crisis.

More information

Opiate Use Disorder and Opiate Overdose

Opiate Use Disorder and Opiate Overdose Opiate Use Disorder and Opiate Overdose Irene Ortiz, MD Medical Director Molina Healthcare of New Mexico and South Carolina Clinical Professor University of New Mexico School of Medicine Objectives DSM-5

More information

Interdisciplinary Management of Opioid Use Disorder in Rural Primary Care Settings

Interdisciplinary Management of Opioid Use Disorder in Rural Primary Care Settings Interdisciplinary Management of Opioid Use Disorder in Rural Primary Care Settings BRIAN GARVEY, MD, MPH REBECCA CANTONE, MD OREGON HEALTH & SCIENCE UNIVERSITY SCAPPOOSE RURAL HEALTH CENTER Disclosures

More information

State Opioid Response (SOR) Grant

State Opioid Response (SOR) Grant State Opioid Response (SOR) Grant Adam Bucon, LSW DMHAS Provider Meeting September 20, 2018 Philip D. Murphy Governor Shereef M. Elnahal Commissioner Sheila Y. Oliver Lt. Governor NJ Opioid Statistics

More information

It s Not Just One More Thing! Overcoming Obstacles for Buprenorphine Treatment by Residents, Faculty and Programs

It s Not Just One More Thing! Overcoming Obstacles for Buprenorphine Treatment by Residents, Faculty and Programs It s Not Just One More Thing! Overcoming Obstacles for Buprenorphine Treatment by Residents, Faculty and Programs Ken Saffier, MD Maureen Strohm, MD May 7, 2017 Disclosures Ken Saffier, MD, has nothing

More information

AGENDA U.S. SURGEON GENERAL, VIVEK MURTHY MD 2/5/2019

AGENDA U.S. SURGEON GENERAL, VIVEK MURTHY MD 2/5/2019 FORMER U.S. SURGEON GENERAL, VIVEK MURTHY MD AN ESTIMATED 20.8 MILLION PEOPLE IN OUR COUNTRY ARE LIVING WITH A SUBSTANCE USE DISORDER. THIS IS SIMILAR TO THE NUMBER OF PEOPLE WHO HAVE DIABETES, AND 1.5

More information

U.S. SURGEON GENERAL, VIVEK MURTHY MD

U.S. SURGEON GENERAL, VIVEK MURTHY MD FORMER U.S. SURGEON GENERAL, VIVEK MURTHY MD AN ESTIMATED 20.8 MILLION PEOPLE IN OUR COUNTRY ARE LIVING WITH A SUBSTANCE USE DISORDER. THIS IS SIMILAR TO THE NUMBER OF PEOPLE WHO HAVE DIABETES, AND 1.5

More information

Hospitals Role in Addressing the Opioid Crisis

Hospitals Role in Addressing the Opioid Crisis Hospitals Role in Addressing the Opioid Crisis Webinar 5: Buprenorphine in the Emergency Department November 14, 2017 Agenda Hospital Based Buprenorphine Initiatives Yngvild Olsen, M.D., Medical Consultant,

More information

What Is Heroin? Examples of Opioids. What Science Says about Opioid Use Disorder and Its Treatment 6/27/2016

What Is Heroin? Examples of Opioids. What Science Says about Opioid Use Disorder and Its Treatment 6/27/2016 What Science Says about Opioid Use Disorder and Its Treatment Perilou Goddard, Ph.D. Department of Psychological Science Northern Kentucky University Examples of Opioids Agonists (activate opioid receptors)

More information

Medication Assisted Treatment. Karen Drexler, MD National Mental Health Program Director-Substance Use Disorders Department of Veterans Affairs

Medication Assisted Treatment. Karen Drexler, MD National Mental Health Program Director-Substance Use Disorders Department of Veterans Affairs Medication Assisted Treatment Karen Drexler, MD National Mental Health Program Director-Substance Use Disorders Department of Veterans Affairs Disclosures Employed by the Department of Veterans Affairs

More information

6/6/2018. Objectives. Outline. Rethinking Medication Treatment for Opioid Use Disorder

6/6/2018. Objectives. Outline. Rethinking Medication Treatment for Opioid Use Disorder Rethinking Medication Treatment for Opioid Use Disorder International Conference on Opioids June 10, 2018 Dustin Patil, MD Fellow, Addiction Psychiatry Boston Medical Center John Renner, MD Professor of

More information

Mission: The Oregon Coalition for Responsible Use of Meds (OrCRM) is a Statewide Coalition launched to prevent overdose, misuse and abuse of

Mission: The Oregon Coalition for Responsible Use of Meds (OrCRM) is a Statewide Coalition launched to prevent overdose, misuse and abuse of Mission: The Oregon Coalition for Responsible Use of Meds (OrCRM) is a Statewide Coalition launched to prevent overdose, misuse and abuse of amphetamines and opioids, both prescription and illicit, among

More information

Shawn A. Ryan MD, MBA President & Chief Medical Officer Board Certified, Addiction Medicine

Shawn A. Ryan MD, MBA President & Chief Medical Officer Board Certified, Addiction Medicine [Patient-focused, evidence-based addiction treatment] Shawn A. Ryan MD, MBA President & Chief Medical Officer Board Certified, Addiction Medicine BrightView Health All Rights Reserved www.brightviewhealth.com

More information

Treatment Approaches for Drug Addiction

Treatment Approaches for Drug Addiction Treatment Approaches for Drug Addiction NOTE: This fact sheet discusses research findings on effective treatment approaches for drug abuse and addiction. If you re seeking treatment, you can call the Substance

More information

LEVEL OF CARE GUIDELINES: PEER SUPPORT SERVICES OPTUM IDAHO MEDICAID

LEVEL OF CARE GUIDELINES: PEER SUPPORT SERVICES OPTUM IDAHO MEDICAID OPTUM IDAHO LEVEL OF CARE GUIDELINES: PEER SUPPORT SERVICES IDAHO MEDICAID LEVEL OF CARE GUIDELINES: PEER SUPPORT SERVICES OPTUM IDAHO MEDICAID Guideline Number: BH803IDPSS_012017 Effective Date: July,

More information

Management Options for Opioid Dependence:

Management Options for Opioid Dependence: Management Options for Opioid Dependence: Policy Implications and Recommendations Dan Ollendorf, PhD Sarah Jane Reed, MSc New England CEPAC Goal: To improve the application of evidence to guide practice

More information

Opioid Use and Justice Involvement: Challenges in Treatment, Engagement, and Continuity

Opioid Use and Justice Involvement: Challenges in Treatment, Engagement, and Continuity Opioid Use and Justice Involvement: Challenges in Treatment, Engagement, and Continuity Holly Hills, Ph.D. June 13, 2017 Department of Mental Health Law and Policy Overview: Persons who have not been in

More information

Opioids Research to Practice

Opioids Research to Practice Opioids Research to Practice CRIT Program May 2009 Daniel P. Alford, MD, MPH Associate Professor of Medicine Boston University School of Medicine Boston Medical Center 32 yo female brought in after heroin

More information

The Opioid Epidemic and PerformRx s Approach to Address It: A Collaborative Model with PBM, Payor and Behavioral Health

The Opioid Epidemic and PerformRx s Approach to Address It: A Collaborative Model with PBM, Payor and Behavioral Health The Opioid Epidemic and PerformRx s Approach to Address It: A Collaborative Model with PBM, Payor and Behavioral Health Andrea Gelzer, M.D., M.S., FACP Senior Vice President and Corporate Chief Medical

More information

ROSC & MAT II: Opioid Treatment Services

ROSC & MAT II: Opioid Treatment Services ROSC & MAT II: Opioid Treatment Services September 23, 2015 Stan DeKemper Executive Director Indiana Credentialing Association on Addiction and Drug Abuse 1 GOALS Review medication assisted recovery Identify

More information

Introduction to the Massachusetts Consultation Service for the Treatment of Addiction and Pain. March 12 and March 13, 2019

Introduction to the Massachusetts Consultation Service for the Treatment of Addiction and Pain. March 12 and March 13, 2019 Introduction to the Massachusetts Consultation Service for the Treatment of Addiction and Pain March 12 and March 13, 2019 Providers Needs Related to Treating Patients with SUD and Chronic Pain Provider

More information

Buprenorphine is the most effective office-based treatment available for heroin and prescription opioid addiction

Buprenorphine is the most effective office-based treatment available for heroin and prescription opioid addiction Buprenorphine is the most effective office-based treatment available for heroin and prescription opioid addiction The Problem The overdose death rate in Missouri and in the country has been rising for

More information

OPIOID SAFE- PRESCRIBING TRAINING IMMERSION (OSTI)

OPIOID SAFE- PRESCRIBING TRAINING IMMERSION (OSTI) OPIOID SAFE- PRESCRIBING TRAINING IMMERSION (OSTI) Case 105- Prep Materials University of Massachusetts Medical School Opioid Conscious Curriculum Learner Prep Objectives The purpose of this prep material

More information

NORTHWEST AIDS EDUCATION AND TRAINING CENTER. Opioid Use Disorders. Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014

NORTHWEST AIDS EDUCATION AND TRAINING CENTER. Opioid Use Disorders. Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014 NORTHWEST AIDS EDUCATION AND TRAINING CENTER Opioid Use Disorders Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014 Opioid Use Disorders Importance of opioid use disorders Screening and

More information

WHAT CAN I EXPECT?: DUAL SUBSTANCE USE AND MENTAL HEALTH TREATMENT FOR MILITARY POPULATIONS

WHAT CAN I EXPECT?: DUAL SUBSTANCE USE AND MENTAL HEALTH TREATMENT FOR MILITARY POPULATIONS WHAT CAN I EXPECT?: DUAL SUBSTANCE USE AND MENTAL HEALTH TREATMENT FOR MILITARY POPULATIONS René Lento, PhD Lauren Brenner, PhD September 25, 2018 DISCLOSURES None HOME BASE PROGRAM 3 LEARNING OBJECTIVES

More information

Treatment Alternatives for Substance Use Disorders

Treatment Alternatives for Substance Use Disorders Treatment Alternatives for Substance Use Disorders Dean Drosnes, MD, FASAM Associate Medical Director Director, Chronic Pain and SUD Program Caron Treatment Centers 1 Disclosure The speaker has no conflict

More information

HHSC LAR Request. Substance Abuse Disorder Coalition. Contact Person: Will Francis Members:

HHSC LAR Request. Substance Abuse Disorder Coalition. Contact Person: Will Francis Members: HHSC LAR Request Substance Abuse Disorder Coalition Contact Person: Will Francis wfrancis.naswtx@socialworkers.org Members: NAMI Texas Children s Defense Fund Texas Communities for Recovery National Association

More information

THE MEDICAL MODEL: ADDICTION IS A BRAIN DISEASE. Judith Martin, MD Medical Director of Substance Use Services San Francisco Dept.

THE MEDICAL MODEL: ADDICTION IS A BRAIN DISEASE. Judith Martin, MD Medical Director of Substance Use Services San Francisco Dept. THE MEDICAL MODEL: ADDICTION IS A BRAIN DISEASE Judith Martin, MD Medical Director of Substance Use Services San Francisco Dept. Public Health disclosures Dr. Martin has no conflict of interest to disclose.

More information

State of Connecticut Department of Mental Health and Addiction Services. State Innovations in Prevention and Treatment of Opioid Use Disorders

State of Connecticut Department of Mental Health and Addiction Services. State Innovations in Prevention and Treatment of Opioid Use Disorders State of Connecticut Department of Mental Health and Addiction Services State Innovations in Prevention and Treatment of Opioid Use Disorders National Academy for State Health Policy October 23, 2017 ~

More information

The Importance of Psychological Treatment and Behavioral Support

The Importance of Psychological Treatment and Behavioral Support The Importance of Psychological Treatment and Behavioral Support Michael W. Otto, PhD Department of Psychological and Brain Science Boston University Conflicts and Acknowledgements No industry funding

More information

Referral to Treatment: Utilizing the ASAM Criteria

Referral to Treatment: Utilizing the ASAM Criteria Referral to Treatment: Utilizing the ASAM Criteria AOAAM Essentials in Addiction Medicine October 22, 2016 East Lansing, MI Stephen A. Wyatt, DO Medical Director, Addiction Medicine Behavioral Health Service

More information

Improving the Quality of Addiction Treatment

Improving the Quality of Addiction Treatment Improving the Quality of Addiction Treatment Expanding Access to Medication-Assisted Treatment in Residential Addiction Treatment Programs Webinar sponsored by RTI International January 18, 2018 RTI International

More information

State Targeted Opioid Response Initiative (STORI) Fee-for-Service (FFS) Open Enrollment

State Targeted Opioid Response Initiative (STORI) Fee-for-Service (FFS) Open Enrollment State Targeted Opioid Response Initiative (STORI) Fee-for-Service (FFS) Open Enrollment DEPARTMENT OF HUMAN SERVICES (DHS) DIVISION OF MENTAL HEALTH & ADDICTION SERVICES (DMHAS) STORI INFORMATIONAL WEBINAR

More information

TREATING OPIOID ADDICTION IN HOMELESS POPULATIONS

TREATING OPIOID ADDICTION IN HOMELESS POPULATIONS TREATING OPIOID ADDICTION IN HOMELESS POPULATIONS Challenges and Opportunities Providing Medication Assisted Treatment (Buprenorphine) August 18, 2016 SPEAKERS TODAY Nilesh Kalyanaraman, MD, Chief Health

More information

Building capacity for a CHC response to Ontario's Opioid Crisis

Building capacity for a CHC response to Ontario's Opioid Crisis Building capacity for a CHC response to Ontario's Opioid Crisis Rob Boyd Oasis Program Director Luc Cormier, RN, MScN Community Health Nurse Sandy Hill Community Health Centre #AOHC2016 @rboyd6 @SandyHillCHC

More information

STARTING SUBOXONE IN PRIMARY CARE

STARTING SUBOXONE IN PRIMARY CARE Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences STARTING SUBOXONE IN PRIMARY CARE MARK DUNCAN MD UNIVERSITY OF WASHINGTON OBJECTIVES 1. Review evidence of how to

More information

Powell Recovery Center

Powell Recovery Center Powell Recovery Center Presentation for The Female Clergy Support Group of MD Powell Recovery Center, Inc. 14 South Broadway Baltimore, MD 21231 410-276-1773 Community Support is Key to the Success of

More information

Kentucky s Strategic Action Plan. Katherine Marks, Ph.D. August 16, 2018

Kentucky s Strategic Action Plan. Katherine Marks, Ph.D. August 16, 2018 Kentucky s Strategic Action Plan Katherine Marks, Ph.D. August 16, 2018 OUTLINE The state & the need The organization of a response The action plan THE STATE AND THE NEED KENTUCKY 4.4 million people 35

More information

Psychosocial Treatments for Opioid Use Disorder Overview

Psychosocial Treatments for Opioid Use Disorder Overview Psychosocial Treatments for Opioid Use Disorder Overview Nalan Ward, MD Director Outpatient Addiction Services Department of Psychiatry Massachusetts General Hospital *Images used for educational purposes

More information

Integrating Primary Care for Addiction Treatment

Integrating Primary Care for Addiction Treatment A23 These presenters have nothing to disclose Integrating Primary Care for Addiction Treatment By Donna Gallbreath, MD Senior Medical Director and Melissa Merrick, LCSW, CDCI Clinical Director of Behavioral

More information

Behavioral Health Best Practices

Behavioral Health Best Practices Behavioral Health Best Practices Rhonda Roper, LCSW, CCM, Behavioral Health Clinical Director Tabitha Miller, LCSW, Behavioral Health Clinical Manager Behavioral Health Overview Behavioral Health (BH)

More information

Treatment Team Approaches in Substance Abuse Treatment

Treatment Team Approaches in Substance Abuse Treatment Treatment Team Approaches in Substance Abuse Treatment PLANT A SEED AND WATCH IT GROW 2 Substance use disorders span a wide variety of problems arising from substance use, and cover 11 different criteria:

More information

Creation of the Brigham Health Bridge Clinic: Immediate Access to SUD treatment

Creation of the Brigham Health Bridge Clinic: Immediate Access to SUD treatment Creation of the Brigham Health Bridge Clinic: Immediate Access to SUD treatment Christin Price, M.D. Program Administrative Director, Bridge Clinic Associate Director, Medical Management & Population Health

More information

Responding to the Opioid Epidemic

Responding to the Opioid Epidemic Responding to the Opioid Epidemic Jessica Gray, MD Addiction Medicine Fellow Boston Medical Center ROME New England August 17, 2017 Disclosures for Jessica Gray, MD No conflicts Learning Objectives Describe

More information

OUTPATIENT TREATMENT WESTPORT, CONNECTICUT

OUTPATIENT TREATMENT WESTPORT, CONNECTICUT OUTPATIENT TREATMENT WESTPORT, CONNECTICUT ABOUT CLEARPOINT At Clearpoint, we focus on healing the whole person: mind, body, and spirit. Our comprehensive care methods set clients up for long-term success

More information

105 Panel: Addressing the Opioid Crisis: Pain Management, Addiction Treatment, and Recovery in the Context of APMs

105 Panel: Addressing the Opioid Crisis: Pain Management, Addiction Treatment, and Recovery in the Context of APMs 105 Panel: Addressing the Opioid Crisis: Pain Management, Addiction Treatment, and Recovery in the Context of APMs Welcome Bill Hazel Former Secretary, Health and Human Resources, Commonwealth of Virginia

More information

Medication Assisted Treatment (MAT) Program. MCPA Presentation Monday, July 24 th, 2017

Medication Assisted Treatment (MAT) Program. MCPA Presentation Monday, July 24 th, 2017 Medication Assisted Treatment (MAT) Program MCPA Presentation Monday, July 24 th, 2017 MyCare Health Center Presenter: Karen Wood, RD CEO Objectives Explain MyCare s MAT program History Statistics Contracts

More information

Opioids Research to Practice

Opioids Research to Practice Opioids Research to Practice CRIT Program May 2008 Daniel P. Alford, MD, MPH Associate Professor of Medicine Boston University School of Medicine Boston Medical Center 32 yo female brought in after heroin

More information

OPIATES IN PRISON. Jeffrey C. Fetter, MD

OPIATES IN PRISON. Jeffrey C. Fetter, MD OPIATES IN PRISON Jeffrey C. Fetter, MD Agenda Opioids in the Correctional Environment MAT and Corrections Substance Abuse Treatment in NH DOC Suboxone Suboxone: Contraband Suboxone Contraband Scale of

More information

Aetna s Initiative on the Opioid Epidemic

Aetna s Initiative on the Opioid Epidemic Aetna s Initiative on the Opioid Epidemic Christopher James D.O., M.P.H. Medical Director, BH- Mid-Atlantic Territory (JamesC1@aetna.com) July 23, 2017 HHS Data on Epidemic Every Day in the U.S. More than

More information

Opioid Dependence 101 and Medication Assisted Treatment

Opioid Dependence 101 and Medication Assisted Treatment Opioid Dependence 101 and Medication Assisted Treatment Dr. Joji Suzuki Director of the Division of Addiction Psychiatry, Brigham & Women s Hospital Assistant Professor of Psychiatry, Harvard Medical School

More information

Science = Solutions For Substance Use Disorders and Infant Outcomes. Wilson M. Compton, M.D., M.P.E. Deputy Director National Institute on Drug Abuse

Science = Solutions For Substance Use Disorders and Infant Outcomes. Wilson M. Compton, M.D., M.P.E. Deputy Director National Institute on Drug Abuse Science = Solutions For Substance Use Disorders and Infant Outcomes Wilson M. Compton, M.D., M.P.E. Deputy Director National Institute on Drug Abuse Science = Solutions Increased Opioid Mortality: Greater

More information

Clackamas County Overdose Prevention and Recovery Support Projects. Apryl L. Herron, MPH Clackamas County Public Health Division

Clackamas County Overdose Prevention and Recovery Support Projects. Apryl L. Herron, MPH Clackamas County Public Health Division Clackamas County Overdose Prevention and Recovery Support Projects Apryl L. Herron, MPH Clackamas County Public Health Division Disclosures No disclosures/financial conflicts of interest Learning Objectives

More information

Opioids Research to Practice

Opioids Research to Practice Opioids Research to Practice CRIT Program May 2010 Daniel P. Alford, MD, MPH Associate Professor of Medicine Boston University School of Medicine Boston Medical Center 32 yo female brought in after heroin

More information

Hospitals Role in Addressing the Opioid Crisis

Hospitals Role in Addressing the Opioid Crisis Hospitals Role in Addressing the Opioid Crisis Webinar 4: Overdose Survivors Outreach Project October 18, 2017 Agenda Overdose Survivors Outreach Project (OSOP) Background Barry Page, Director of Early

More information